Cessatech
16.00 DKK
-7.83 %
Less than 1K followers
CESSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-7.83 %
-12.47 %
+0.25 %
+14.29 %
+41.59 %
+76.21 %
+912.66 %
+5.33 %
+48.36 %
Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company focuses on specialty products designed for use in clinical settings and advances its programs through a partnership-based development model. Founded in 2020, Cessatech is headquartered in Denmark and led by a team with experience across drug development and commercialization.
Read moreMarket cap
297.22M DKK
Turnover
374.16K DKK
Revenue
5.72M
EBIT %
-261.75 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
30/3
2026
General meeting '26
28/5
2026
Interim report Q1'26
28/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Cessatech A/S Announces Financial Results for the Full Year 2025
Cessatech: Welcome to the first quarter of 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools